Correlation Between Pacira BioSciences, and Lantheus Holdings
Can any of the company-specific risk be diversified away by investing in both Pacira BioSciences, and Lantheus Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pacira BioSciences, and Lantheus Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pacira BioSciences, and Lantheus Holdings, you can compare the effects of market volatilities on Pacira BioSciences, and Lantheus Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pacira BioSciences, with a short position of Lantheus Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pacira BioSciences, and Lantheus Holdings.
Diversification Opportunities for Pacira BioSciences, and Lantheus Holdings
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Pacira and Lantheus is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Pacira BioSciences, and Lantheus Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lantheus Holdings and Pacira BioSciences, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pacira BioSciences, are associated (or correlated) with Lantheus Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lantheus Holdings has no effect on the direction of Pacira BioSciences, i.e., Pacira BioSciences, and Lantheus Holdings go up and down completely randomly.
Pair Corralation between Pacira BioSciences, and Lantheus Holdings
Given the investment horizon of 90 days Pacira BioSciences, is expected to under-perform the Lantheus Holdings. But the stock apears to be less risky and, when comparing its historical volatility, Pacira BioSciences, is 1.05 times less risky than Lantheus Holdings. The stock trades about -0.01 of its potential returns per unit of risk. The Lantheus Holdings is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 7,308 in Lantheus Holdings on November 20, 2024 and sell it today you would earn a total of 686.00 from holding Lantheus Holdings or generate 9.39% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Pacira BioSciences, vs. Lantheus Holdings
Performance |
Timeline |
Pacira BioSciences, |
Lantheus Holdings |
Pacira BioSciences, and Lantheus Holdings Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pacira BioSciences, and Lantheus Holdings
The main advantage of trading using opposite Pacira BioSciences, and Lantheus Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pacira BioSciences, position performs unexpectedly, Lantheus Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lantheus Holdings will offset losses from the drop in Lantheus Holdings' long position.Pacira BioSciences, vs. Phibro Animal Health | Pacira BioSciences, vs. Dr Reddys Laboratories | Pacira BioSciences, vs. Collegium Pharmaceutical | Pacira BioSciences, vs. Prestige Brand Holdings |
Lantheus Holdings vs. Neurocrine Biosciences | Lantheus Holdings vs. Ironwood Pharmaceuticals | Lantheus Holdings vs. Alkermes Plc | Lantheus Holdings vs. Avadel Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |